EP1173478A4 - 49 humane sekretierte Proteine - Google Patents

49 humane sekretierte Proteine

Info

Publication number
EP1173478A4
EP1173478A4 EP00918537A EP00918537A EP1173478A4 EP 1173478 A4 EP1173478 A4 EP 1173478A4 EP 00918537 A EP00918537 A EP 00918537A EP 00918537 A EP00918537 A EP 00918537A EP 1173478 A4 EP1173478 A4 EP 1173478A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00918537A
Other languages
English (en)
French (fr)
Other versions
EP1173478A1 (de
Inventor
Craig A Rosen
Steven M Ruben
George Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1173478A1 publication Critical patent/EP1173478A1/de
Publication of EP1173478A4 publication Critical patent/EP1173478A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
EP00918537A 1999-04-09 2000-04-06 49 humane sekretierte Proteine Withdrawn EP1173478A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12869599P 1999-04-09 1999-04-09
US128695P 1999-04-09
US17605200P 2000-01-14 2000-01-14
US176052P 2000-01-14
PCT/US2000/009070 WO2000061628A1 (en) 1999-04-09 2000-04-06 49 human secreted proteins

Publications (2)

Publication Number Publication Date
EP1173478A1 EP1173478A1 (de) 2002-01-23
EP1173478A4 true EP1173478A4 (de) 2003-02-05

Family

ID=26826855

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00918537A Withdrawn EP1173478A4 (de) 1999-04-09 2000-04-06 49 humane sekretierte Proteine

Country Status (5)

Country Link
EP (1) EP1173478A4 (de)
JP (1) JP2003500020A (de)
AU (1) AU3933300A (de)
CA (1) CA2370523A1 (de)
WO (1) WO2000061628A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014466A1 (en) * 1996-10-01 1998-04-09 Progentior, Inc. Polymorphisms and new genes in the region of the human hemochromatosis gene
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (en) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
WO1998051790A1 (en) * 1997-05-13 1998-11-19 Amrad Operations Pty. Ltd. A novel nucleic acid molecule
EP0879887A1 (de) * 1997-05-21 1998-11-25 Smithkline Beecham Corporation Ein menschliches Gen mit Ähnlichkeit zum sekretierten Murinen Protein SDF5 (ATG-1622)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014466A1 (en) * 1996-10-01 1998-04-09 Progentior, Inc. Polymorphisms and new genes in the region of the human hemochromatosis gene
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (en) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
WO1998051790A1 (en) * 1997-05-13 1998-11-19 Amrad Operations Pty. Ltd. A novel nucleic acid molecule
EP0879887A1 (de) * 1997-05-21 1998-11-25 Smithkline Beecham Corporation Ein menschliches Gen mit Ähnlichkeit zum sekretierten Murinen Protein SDF5 (ATG-1622)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 4 July 1997 (1997-07-04), XP002208049 *
DATABASE EMBL 5 November 1997 (1997-11-05), XP002208050 *
See also references of WO0061628A1 *

Also Published As

Publication number Publication date
AU3933300A (en) 2000-11-14
EP1173478A1 (de) 2002-01-23
JP2003500020A (ja) 2003-01-07
WO2000061628A1 (en) 2000-10-19
CA2370523A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
EP1218408A4 (de) 32 menschliche, sekretierte proteine
EP1212343A4 (de) 52 menschliche sekretierte proteine
EP1181390A4 (de) 27 menschliche, sekretierte proteine
EP1224285A4 (de) 27 menschliche sekretierte proteine
EP1212342A4 (de) 18 human-sekretierte proteine
EP1226231A4 (de) 19 humane sekretierte proteine
EP1175438A4 (de) 62 humane sekretierte proteine
EP1192278A4 (de) 48 menschliche sekretierte proteine
EP1192176A4 (de) 49 menschliche sekretierte proteine
EP1175439A4 (de) 49 humane sekretierte proteine
EP1165827A4 (de) 45 humane sekretierte proteine
EP1159284A4 (de) 33 human sekrteierte proteine
EP1189917A4 (de) 48 menschliche sekretierte proteine
EP1185543A4 (de) 50 human-sekretierte proteine
EP1224201A4 (de) 32 vom menschen abgesonderte proteine
EP1173477A4 (de) 49 humane sekretierte Proteine
EP1206573A4 (de) 26 humane sekretionsproteine
EP1203005A4 (de) 25 humane sekretierte proteine
EP1171460A4 (de) 48 menschliche sekretierte proteine
EP1169332A4 (de) 49 human sekrtierte proteine
EP1165602A4 (de) 49 menschliche, sekretierte proteine
EP1144614A4 (de) Menschliche, ausgeschiedene proteine
EP1165828A4 (de) 50 menschliche sekretierte proteine
EP1228082A4 (de) 29 humansekretierte proteine
EP1185285A4 (de) 49 humane sekretierte proteine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07K 14/47 A, 7C 12N 5/10 B, 7C 12N 15/16 B, 7C 12N 15/12 B, 7C 12N 15/63 B, 7C 12N 15/64 B

A4 Supplementary search report drawn up and despatched

Effective date: 20021220

17Q First examination report despatched

Effective date: 20030423

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040504